The Peptide Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Peptide Therapeutics Market?
The Peptide Therapeutics Global Market Report 2025 shows that the market size experienced a significant rise in recent years. It was valued at $45.15 billion in 2024, and is projected to increase to $49.67 billion in 2025, following a compound annual growth rate of 10.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Peptide Therapeutics Industry?
The Peptide Therapeutics Global Market is expected to reach a size of $76.64 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.5%.
Download Your Free Sample of the 2025 Peptide Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Peptide Therapeutics Market?
The key drivers in the peptide therapeutics market are:
• Rising demand for personalized medicine
• Expanding use of peptides in immunotherapy
• Advancements in peptide delivery systems
• Emerging peptide targets in infectious diseases
Global Market Segmentation: Identifying Major Peptide Therapeutics Industry Segments
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Pre-order the 2025 Peptide Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Peptide Therapeutics Market?
The key trends in the peptide therapeutics market are:
• Technological advancements in peptide synthesis are playing a crucial role in shaping the market.
• The trend of major investments and funding is also affecting the growth of the market.
• There is an increasing emphasis on peptide drug safety in the emerging market.
• The integration of artificial intelligence in the peptide therapeutics sector is another emerging trend.
Who Are the Top Competitors & Leading Players in the Peptide Therapeutics Market?
Major companies in the peptide therapeutics market are:
• Pfizer Inc.
• Jhonson & Jhonson
• Abbvie Inc.
• Novartis AG
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Sanofi SA
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk AS
• Teva Pharmaceuticals Industries Ltd.
• Bachem Holding AG
• PolyPeptide Laboratories BV
• Arcus Biosciences Inc.
• Pepscan Therapeutics
• Peptech Inc.
• Peptide Logic Inc.
• SELLAS Life Sciences Group
• Ever Neuro Pharma GmbH
• Zealand Pharma AG
• PepGen Inc.
• Pepticom S.A.
• Peptide Technologies Corporation
• SynPeptide Inc.
• Peptimmune Inc.
• Merck & Co Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the peptide therapeutics market in 2024
